These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34087447)

  • 21. Chemical Derivatization of the Anticancer Agent Cabazitaxel Using a Polyunsaturated Fatty Acid for Safe Drug Delivery
    Lu Z; Li T; Ren L; Zhou L; Wan J; Wu J; Qiao Y; Xie H; Zheng S; Wang H
    J Biomed Nanotechnol; 2018 Nov; 14(11):1853-1865. PubMed ID: 30165923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-assembling prodrug nanotherapeutics for synergistic tumor targeted drug delivery.
    Wang Z; Chen J; Little N; Lu J
    Acta Biomater; 2020 Jul; 111():20-28. PubMed ID: 32454086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current development of cabazitaxel drug delivery systems.
    Sun B; Lovell JF; Zhang Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1854. PubMed ID: 36161272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pH responsive biodegradable nanogels for sustained release of bleomycin.
    Sahu P; Kashaw SK; Kushwah V; Sau S; Jain S; Iyer AK
    Bioorg Med Chem; 2017 Sep; 25(17):4595-4613. PubMed ID: 28734664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity.
    Wang H; Lu Z; Wang L; Guo T; Wu J; Wan J; Zhou L; Li H; Li Z; Jiang D; Song P; Xie H; Zhou L; Xu X; Zheng S
    Cancer Res; 2017 Dec; 77(24):6963-6974. PubMed ID: 29055017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Wnt non-canonical signaling modulates cabazitaxel sensitivity in prostate cancer cells.
    Sennoune SR; Nelius T; Jarvis C; Pruitt K; Kottapalli KR; Filleur S
    PLoS One; 2020; 15(6):e0234078. PubMed ID: 32484838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors? An update on the preclinical development of cabazitaxel.
    Sémiond D; Sidhu SS; Bissery MC; Vrignaud P
    Cancer Chemother Pharmacol; 2013 Sep; 72(3):515-28. PubMed ID: 23820961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
    Akinboye ES; Brennen WN; Rosen DM; Bakare O; Denmeade SR
    Prostate; 2016 Jun; 76(8):703-14. PubMed ID: 26835873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A bottlebrush-architectured dextran polyprodrug as an acidity-responsive vector for enhanced chemotherapy efficiency.
    Zhang T; Wang Y; Ma X; Hou C; Lv S; Jia D; Lu Y; Xue P; Kang Y; Xu Z
    Biomater Sci; 2020 Jan; 8(1):473-484. PubMed ID: 31755481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymersome nanoreactors with tumor pH-triggered selective membrane permeability for prodrug delivery, activation, and combined oxidation-chemotherapy.
    Mukerabigwi JF; Yin W; Zha Z; Ke W; Wang Y; Chen W; Japir AAMM; Wang Y; Ge Z
    J Control Release; 2019 Jun; 303():209-222. PubMed ID: 31026547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.
    Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z
    Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-angiogenesis therapy in the Vx2 rabbit cancer model with a lipase-cleavable Sn 2 taxane phospholipid prodrug using α(v)β₃-targeted theranostic nanoparticles.
    Pan D; Schmieder AH; Wang K; Yang X; Senpan A; Cui G; Killgore K; Kim B; Allen JS; Zhang H; Caruthers SD; Shen B; Wickline SA; Lanza GM
    Theranostics; 2014; 4(6):565-78. PubMed ID: 24723979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taxane-based Combination Therapies for Metastatic Prostate Cancer.
    Corn PG; Agarwal N; Araujo JC; Sonpavde G
    Eur Urol Focus; 2019 May; 5(3):369-380. PubMed ID: 29275145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA.
    Kang Y; Lu L; Lan J; Ding Y; Yang J; Zhang Y; Zhao Y; Zhang T; Ho RJY
    Acta Biomater; 2018 Mar; 68():137-153. PubMed ID: 29288085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A facile approach for dual-responsive prodrug nanogels based on dendritic polyglycerols with minimal leaching.
    Zhang X; Achazi K; Steinhilber D; Kratz F; Dernedde J; Haag R
    J Control Release; 2014 Jan; 174():209-16. PubMed ID: 24225227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
    Wang Z; Wu H; Liu P; Zeng F; Wu S
    Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Docetaxel/cabazitaxel and fatty acid binding protein 5 inhibitors produce synergistic inhibition of prostate cancer growth.
    Carbonetti G; Converso C; Clement T; Wang C; Trotman LC; Ojima I; Kaczocha M
    Prostate; 2020 Jan; 80(1):88-98. PubMed ID: 31661167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biodegradable Zwitterionic Nanogels with Long Circulation for Antitumor Drug Delivery.
    Men Y; Peng S; Yang P; Jiang Q; Zhang Y; Shen B; Dong P; Pang Z; Yang W
    ACS Appl Mater Interfaces; 2018 Jul; 10(28):23509-23521. PubMed ID: 29947223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Glutathione (GSH)-Responsive Near-Infrared (NIR) Theranostic Prodrug for Cancer Therapy and Imaging.
    Kong F; Liang Z; Luan D; Liu X; Xu K; Tang B
    Anal Chem; 2016 Jun; 88(12):6450-6. PubMed ID: 27216623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facile preparation of pH/reduction dual-responsive prodrug nanohydrogels for tumor-specific intracellular triggered release with enhanced anticancer efficiency.
    Zhou T; Jia X; Zhao X; Li J; Liu P
    J Mater Chem B; 2017 Apr; 5(15):2840-2848. PubMed ID: 32264171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.